adenine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rose, S | 1 |
| Jackson, MJ | 1 |
| Smith, LA | 1 |
| Stockwell, K | 1 |
| Johnson, L | 1 |
| Carminati, P | 1 |
| Jenner, P | 1 |
1 other study available for adenine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Callithrix; Dose-Response | 2006 |